Co-administration of liraglutide with insulin detemir demonstrates additive pharmacodynamic effects with no pharmacokinetic interaction. [electronic resource]
Producer: 20110516Description: 75-80 p. digitalISSN:- 1463-1326
- Area Under Curve
- Diabetes Mellitus, Type 2 -- blood
- Drug Interactions
- Drug Therapy, Combination
- Female
- Glucagon-Like Peptide 1 -- analogs & derivatives
- Humans
- Hypoglycemic Agents -- pharmacokinetics
- Insulin -- administration & dosage
- Insulin Detemir
- Insulin, Long-Acting
- Liraglutide
- Male
- Middle Aged
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.